Sun Pharma, Cipla Among Systematix's Top Pharma Picks Ahead Of Q1 Results — Full List Inside
The brokerage expects domestic-focused pharma companies to outperform peers exposed to high-value US generic opportunities, with Sun Pharma, Cipla and Jubilant Pharmova emerging as its preferred picks ahead of Q1 FY27 results.
\